Shalby Ltd (SHALBY) Q1FY26 Concall Summary - Jun-2025 Qtr
Performance Overview
- Shalby achieved its highest-ever quarterly revenue, exceeding INR 300 Crores for the first time.
- Consolidated revenue grew by 12.3% QoQ and 5.1% YoY, driven by strong performance across various segments.
- Standalone hospital business revenue grew by 13.1% QoQ, remaining flat YoY.
- Shalby MedTech, the implant business, showed robust growth with a 74.2% YoY increase in consolidated revenue and a substantial 271% YoY increase in standalone revenue.
- The company maintains a healthy balance sheet with a low gearing ratio of 0.3x.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.